diclazuril and Protozoan-Infections--Animal

diclazuril has been researched along with Protozoan-Infections--Animal* in 2 studies

Reviews

1 review(s) available for diclazuril and Protozoan-Infections--Animal

ArticleYear
Review of triazine antiprotozoal drugs used in veterinary medicine.
    Journal of veterinary pharmacology and therapeutics, 2018, Volume: 41, Issue:2

    Triazines are relatively new antiprotozoal drugs that have successfully controlled coccidiosis and equine protozoal myeloencephalitis. These drugs have favorably treated other protozoal diseases such as neosporosis and toxoplasmosis. In this article, we discuss the pharmacological characteristics of five triazines, toltrazuril, ponazuril, clazuril, diclazuril, and nitromezuril which are used in veterinary medicine to control protozoal diseases which include coccidiosis, equine protozoal myeloencephalitis, neosporosis, and toxoplasmosis.

    Topics: Acetonitriles; Animals; Antiprotozoal Agents; Coccidiosis; Encephalomyelitis, Equine; Horses; Nitriles; Protozoan Infections, Animal; Toxoplasmosis, Animal; Triazines

2018

Other Studies

1 other study(ies) available for diclazuril and Protozoan-Infections--Animal

ArticleYear
Effect of subcutaneously administered diclazuril on the output of Eimeria species oocysts by experimentally infected rabbits.
    The Veterinary record, 2008, Feb-02, Volume: 162, Issue:5

    The effect of subcutaneously injected diclazuril on the output of Eimeria species oocysts was studied in experimentally infected rabbits. Diclazuril was administered either prophylactically at 0.5, 1 or 2 mg/kg bodyweight two days before each rabbit was inoculated with 20,000 oocysts of a mixed-species field isolate of Eimeria or therapeutically at 1, 2 or 4 mg/kg bodyweight five days after they were inoculated. The prophylactic treatments significantly reduced (P<0.05) the output of oocysts in faeces and the numbers in the rabbits' livers at all doses. The therapeutic treatment at 4 mg/kg also caused a significant reduction (P<0.05) in oocyst shedding, but the lower doses resulted in only a moderate reduction. The shedding of the pathogenic species Eimeria stiedae, Eimeria magna, Eimeria irresidua, Eimeria flavescens, Eimeria piriformis and Eimeria intestinalis was significantly reduced (P<0.05) in all the treated groups. The burden of oocysts in the livers of the therapeutic groups (4000 to 9000) were significantly lower (P<0.05) than in the inoculated but untreated control group (23,000), but higher than in the prophylactic groups (around 1000).

    Topics: Administration, Oral; Animals; Coccidiosis; Coccidiostats; Eimeria; Feces; Female; Injections, Subcutaneous; Liver; Male; Nitriles; Oocysts; Protozoan Infections, Animal; Rabbits; Robenidine; Time Factors; Triazines

2008